CTAP (trifluoroacetate salt) |
| カタログ番号GC43327 |
CTAPは、水溶性の環状オクタペプチドであり、μオピオイド受容体（IC50 = 3.5 nM）に対して選択的な受容体拮抗剤であり、δ受容体（IC50 = 4,500 nM）には作用しません。
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CTAP is a water soluble, cyclic octapeptide which acts as a receptor antagonist that is selective for the µ opioid receptor (IC50 = 3.5 nM) over the δ receptor (IC50 = 4,500 nM). It is a poor antagonist of the somatostatin receptor (IC50 = 14.3 μM). CTAP is at least 10-fold more potent than naltrexone as an antagonist of diverse compounds which have antinociceptive effects through the µ opioid receptor. It resists enzymatic metabolism in the blood and enters the brain and cerebrospinal fluid.
Average Rating: 5 (Based on Reviews and 28 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *